Squarepoint Ops LLC lifted its position in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 72.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 64,947 shares of the health services provider’s stock after purchasing an additional 27,353 shares during the quarter. Squarepoint Ops LLC owned approximately 0.20% of Amedisys worth $5,962,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in AMED. Treasurer of the State of North Carolina boosted its holdings in shares of Amedisys by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider’s stock valued at $1,350,000 after acquiring an additional 140 shares during the period. Arizona State Retirement System grew its position in Amedisys by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider’s stock worth $840,000 after purchasing an additional 177 shares during the last quarter. Bridge City Capital LLC grew its position in Amedisys by 0.8% during the 1st quarter. Bridge City Capital LLC now owns 29,861 shares of the health services provider’s stock worth $2,752,000 after purchasing an additional 231 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in Amedisys by 0.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider’s stock valued at $2,876,000 after purchasing an additional 255 shares during the period. Finally, Texas Permanent School Fund Corp raised its holdings in shares of Amedisys by 1.4% in the first quarter. Texas Permanent School Fund Corp now owns 28,560 shares of the health services provider’s stock valued at $2,632,000 after buying an additional 381 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on AMED shares. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target on the stock. in a report on Monday, July 29th. Cantor Fitzgerald reissued a “neutral” rating and issued a $101.00 target price on shares of Amedisys in a report on Thursday, July 25th. Finally, William Blair cut Amedisys from an “outperform” rating to a “market perform” rating in a research note on Monday, July 1st. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $100.67.
Amedisys Trading Down 0.5 %
NASDAQ AMED opened at $96.63 on Monday. Amedisys, Inc. has a 52-week low of $89.55 and a 52-week high of $98.95. The firm has a 50-day moving average price of $97.61 and a 200 day moving average price of $94.98. The stock has a market capitalization of $3.16 billion, a P/E ratio of -150.98, a P/E/G ratio of 1.90 and a beta of 0.78. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.
Amedisys (NASDAQ:AMED – Get Free Report) last posted its quarterly earnings results on Wednesday, July 24th. The health services provider reported $1.32 EPS for the quarter, beating the consensus estimate of $1.22 by $0.10. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. The business had revenue of $591.19 million during the quarter, compared to analysts’ expectations of $579.34 million. Equities research analysts expect that Amedisys, Inc. will post 4.66 EPS for the current year.
About Amedisys
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Further Reading
- Five stocks we like better than Amedisys
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- Earnings Per Share Calculator: How to Calculate EPS
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- MarketBeat Week in Review – 9/23 – 9/27
Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys, Inc. (NASDAQ:AMED – Free Report).
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.